Presence of Somatic Mutations in Most Early-Stage Pancreatic Intraepithelial Neoplasia

Pancreatic Cancer

Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202

Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses

Jones, S., Zhang, X., Parsons, D. W., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Kamiyama, H., Jimeno, A., et al. (2008) · Science · doi:10.1126/science.1164368 · Cited by 3,969

Circulating mutant DNA to assess tumor dynamics

Diehl, F., Schmidt, K., Choti, M. A., Romans, K. E., Goodman, S. N., Li, M., Thornton, K. A., Agrawal, N., Sokoll, L. J., Szabo, S., et al. (2008) · Nature Medicine · doi:10.1038/nm.1789 · Cited by 2,746

Pancreatic cancer

Vincent, A., Herman, J. M., Schulick, R., Hruban, R. H., & Goggins, M. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62307-0 · Cited by 2,678

Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse

Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471

Pancreatic Intraepithelial Neoplasia: A New Nomenclature and Classification System for Pancreatic Duct Lesions

Hruban, R. H., Adsay, N. V., Albores–Saavedra, J., Compton, C., Garrett, E. S., Goodman, S. N., Kern, S. E., Klimstra, D. S., Klöppel, G., Longnecker, D. S., et al. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200105000-00003 · Cited by 1,126

Senescence-messaging secretome: SMS-ing cellular stress

Kuilman, T., & Peeper, D. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2560 · Cited by 909

Progression model for pancreatic cancer.

Hruban, R. H., Goggins, M., Parsons, J., & Kern, S. E. (2000) · PubMed · Cited by 872

Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development

Wu, J., Matthaei, H., Maitra, A., Molin, M. D., Wood, L., Eshleman, J., Goggins, M., Canto, M., Schulick, R., Edil, B., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002543 · Cited by 786

When cells get stressed: an integrative view of cellular senescence

Ben-Porath, I., & Weinberg, R. A. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420663 · Cited by 404

Pancreatic Cancer Signaling Pathways, Genetic Alterations, and Tumor Microenvironment: The Barriers Affecting the Method of Treatment

Javadrashid, D., Baghbanzadeh, A., Derakhshani, A., Leone, P., Silvestris, N., Racanelli, V., Solimando, A. G., & Baradaran, B. (2021) · Biomedicines · doi:10.3390/biomedicines9040373 · Cited by 90

GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas

Hosoda, W., Sasaki, E., Murakami, Y., Yamao, K., Shimizu, Y., & Yatabe, Y. (2015) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-015-1751-6 · Cited by 88

Locally Advanced Pancreatic Cancer: A Review of Local Ablative Therapies

Ruarus, A. H., Vroomen, L. G. P. H., Puijk, R. S., Scheffer, H. J., & Meijerink, M. R. (2018) · Cancers · doi:10.3390/cancers10010016 · Cited by 87

Cellular determinants and therapeutic implications of inflammation in pancreatic cancer

Stone, M. L., & Beatty, G. L. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.05.012 · Cited by 87

Novel Applications of Mesenchymal Stem Cell-Derived Exosomes for Myocardial Infarction Therapeutics

Tan, S. J. O., Floriano, J. F., Nicastro, L., Emanueli, C., & Catapano, F. (2020) · Biomolecules · doi:10.3390/biom10050707 · Cited by 85

Pathology of pancreatic ductal adenocarcinoma: Facts, challenges and future developments

Esposito, I. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i38.13833 · Cited by 95

KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops

Eibl, G., & Rozengurt, E. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.10.007 · Cited by 88

The conflicting roles of tumor stroma in pancreatic cancer and their contribution to the failure of clinical trials: a systematic review and critical appraisal

Bijlsma, M. F., & van Laarhoven, H. W. M. (2015) · Cancer and Metastasis Reviews · doi:10.1007/s10555-014-9541-1 · Cited by 84

High mesothelin expression in advanced lung adenocarcinoma is associated withKRASmutations and a poor prognosis

Thomas, A., Chen, Y., Steinberg, S. M., Luo, J., Pack, S., Raffeld, M. A., Abdullaev, Z., Alewine, C., Rajan, A., Giaccone, G., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3429 · Cited by 84

KRASmutations in blood circulating cell-free DNA: a pancreatic cancer case-control

Calvez‐Kelm, F. L., Foll, M., Wozniak, M. B., Delhomme, T. M., Durand, G., Chopard, P., Pertesi, M., Fabiánová, E., Adamčáková, Z. K., Holcátová, I., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12386 · Cited by 85

Circulating Tumor Cells in Pancreatic Cancer: Current Perspectives

Martini, V., Timme‐Bronsert, S., Fichtner‐Feigl, S., Hoeppner, J., & Kulemann, B. (2019) · Cancers · doi:10.3390/cancers11111659 · Cited by 83

Lipid Metabolism Regulates Oxidative Stress and Ferroptosis in RAS-Driven Cancers: A Perspective on Cancer Progression and Therapy

Bartolacci, C., Andreani, C., Elgammal, Y., & Scaglioni, P. P. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.706650 · Cited by 86

KRAS and Guanine Nucleotide-Binding Protein Mutations in Pancreatic Juice Collected From the Duodenum of Patients at High Risk for Neoplasia Undergoing Endoscopic Ultrasound

Eshleman, J. R., Norris, A. L., Sadakari, Y., Debeljak, M., Borges, M. W., Harrington, C. T., Lin, E. I., Brant, A., Barkley, T., Almario, J. A., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.11.028 · Cited by 82

Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy

Sugimori, M., Sugimori, K., Tsuchiya, H., Suzuki, Y., Tsuyuki, S., Kaneta, Y., Hirotani, A., Sanga, K., Tozuka, Y., Komiyama, S., et al. (2019) · Cancer Science · doi:10.1111/cas.14245 · Cited by 81

Precancerous lesions of the pancreas

Zamboni, G., Hirabayashi, K., Castelli, P., & Lennon, A. M. (2013) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2013.04.001 · Cited by 83

Pancreatic Juice Mutation Concentrations Can Help Predict the Grade of Dysplasia in Patients Undergoing Pancreatic Surveillance

Suenaga, M., Yu, J., Shindo, K., Tamura, K., Almario, J. A., Zaykoski, C., Witmer, P. D., Fesharakizadeh, S., Borges, M., Lennon, A.-M., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2463 · Cited by 81

Molecular pathways in pancreatic carcinogenesis

Macgregor‐Das, A. M., & Iacobuzio–Donahue, C. A. (2012) · Journal of Surgical Oncology · doi:10.1002/jso.23213 · Cited by 80

Translational Therapeutic Opportunities in Ductal Adenocarcinoma of the Pancreas

Hidalgo, M. M., & Hoff, D. D. V. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1327 · Cited by 81

Long non-coding RNAs in cancer invasion and metastasis

Shen, X.-H., Qi, P., & Du, X. (2014) · Modern Pathology · doi:10.1038/modpathol.2014.75 · Cited by 79

Circulating biomarkers for early diagnosis of pancreatic cancer: facts and hopes.

Zhang, X., Shi, S., Zhang, B., Ni, Q., Yu, X., & Xu, J. (2018) · PubMed Central · Cited by 78

In vivo reprogramming drives Kras-induced cancer development

Shibata, H., Komura, S., Yamada, Y., Sankoda, N., Tanaka, A., Ukai, T., Kabata, M., Sakurai, S., Kuze, B., Woltjen, K., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04449-5 · Cited by 76

Pathological and Molecular Evaluation of Pancreatic Neoplasms

Rishi, A., Goggins, M., Wood, L. D., & Hruban, R. H. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.12.004 · Cited by 79

Activating GNAS and KRAS mutations in gastric foveolar metaplasia, gastric heterotopia, and adenocarcinoma of the duodenum

Matsubara, A., Ogawa, R., Suzuki, H., Oda, I., Taniguchi, H., Kanai, Y., Kushima, R., & Sekine, S. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.104 · Cited by 76

Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma

McIntyre, C. A., Lawrence, S., Richards, A. L., Chou, J. F., Wong, W., Capanu, M., Berger, M. F., Donoghue, M. T. A., Yu, K. H., Varghese, A. M., et al. (2020) · Cancer · doi:10.1002/cncr.33038 · Cited by 75

Rigidity controls human desmoplastic matrix anisotropy to enable pancreatic cancer cell spread via extracellular signal-regulated kinase 2

Malik, R., Luong, T., Cao, X., Han, B., Shah, N., Franco-Barraza, J., Han, L., Shenoy, V. B., Lelkes, P. I., & Cukierman, E. (2019) · Matrix Biology · doi:10.1016/j.matbio.2018.11.001 · Cited by 74

Metastasis in Pancreatic Ductal Adenocarcinoma: Current Standing and Methodologies

Pereira, M. A., & Chio, I. I. C. (2019) · Genes · doi:10.3390/genes11010006 · Cited by 75

Diabetes and Pancreatic Cancer—A Dangerous Liaison Relying on Carbonyl Stress

Menini, S., Iacobini, C., Vitale, M., Pesce, C. M., & Pugliese, G. (2021) · Cancers · doi:10.3390/cancers13020313 · Cited by 79

ZDHHC20-mediated S-palmitoylation of YTHDF3 stabilizes MYC mRNA to promote pancreatic cancer progression

Zhang, H., Sun, Y., Wang, Z., Huang, X., Tang, L., Jiang, K., & Jin, X. (2024) · Nature Communications · doi:10.1038/s41467-024-49105-3 · Cited by 75

Reprogramming of Amino Acid Metabolism in Pancreatic Cancer: Recent Advances and Therapeutic Strategies

Xu, R., Yang, J., Ren, B., Wang, H., Yang, G., Chen, Y., You, L., & Zhao, Y. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.572722 · Cited by 74

Rapid acceleration of KRAS-mutant pancreatic carcinogenesis via remodeling of tumor immune microenvironment by PPARδ

Liu, Y., Deguchi, Y., Wei, D., Liu, F., Moussalli, M. J., Deguchi, E., Li, D., Wang, H., Valentin, L. A., Colby, J. K., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30392-7 · Cited by 74

Progress in the Treatment of Metastatic Pancreatic Cancer and the Search for Next Opportunities

Ko, A. H. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.7625 · Cited by 74

Opportunities and Challenges for Pancreatic Circulating Tumor Cells

Nagrath, S., Jack, R. M., Sahai, V., & Simeone, D. M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.05.052 · Cited by 73

Obesity and Pancreatic Cancer: Insight into Mechanisms

Eibl, G., & Rozengurt, E. (2021) · Cancers · doi:10.3390/cancers13205067 · Cited by 76

Pancreatic adenocarcinoma pathology: changing "landscape".

Brosens, L. A. A., Hackeng, W. M., Offerhaus, G. J. A., Hruban, R. H., & Wood, L. D. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2078-6891.2015.032 · Cited by 73

Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward

Khan, M. A., Azim, S., Zubair, H., Bhardwaj, A., Patel, G. K., Khushman, M. M., Singh, S., & Singh, A. P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040779 · Cited by 73

Deciphering the role of hedgehog signaling in pancreatic cancer

Gu, D., Kelly, E., & Xie, J. (2016) · Journal of Biomedical Research · doi:10.7555/jbr.30.20150107 · Cited by 70

Molecular analysis of EUS-acquired pancreatic cyst fluid for KRAS and GNAS mutations for diagnosis of intraductal papillary mucinous neoplasia and mucinous cystic lesions: a systematic review and meta-analysis

McCarty, T. R., Paleti, S., & Rustagi, T. (2021) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2020.12.014 · Cited by 72

Oral bacteria accelerate pancreatic cancer development in mice

Saba, E., Farhat, M., Daoud, A., Khashan, A., Forkush, E., Menahem, N. H., Makkawi, H., Pandi, K., Angabo, S., Kawasaki, H., et al. (2024) · Gut · doi:10.1136/gutjnl-2023-330941 · Cited by 78

PanIN and CAF transitions in pancreatic carcinogenesis revealed with spatial data integration

Bell, A. T. F., Mitchell, J. T., Kiemen, A. L., Lyman, M. R., Fujikura, K., Lee, J. W., Coyne, E. M., Shin, S. M., Nagaraj, S., Deshpande, A. M., et al. (2024) · Cell Systems · doi:10.1016/j.cels.2024.07.001 · Cited by 77

GNAS and KRAS Mutations are Common in Intraductal Papillary Neoplasms of the Bile Duct

Sasaki, M., Matsubara, T., Nitta, T., Sato, Y., & Nakanuma, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081706 · Cited by 66

Molecular Events in the Natural History of Pancreatic Cancer

Oldfield, L. E., Connor, A. A., & Gallinger, S. (2017) · Trends in cancer · doi:10.1016/j.trecan.2017.04.005 · Cited by 65

Deep Sequencing of Cancer-Related Genes Revealed GNAS Mutations to Be Associated with Intraductal Papillary Mucinous Neoplasms and Its Main Pancreatic Duct Dilation

Takano, S., Fukasawa, M., Maekawa, S., Kadokura, M., Miura, M., Shindo, H., Takahashi, E., Sato, T., & Enomoto, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098718 · Cited by 64

ETS-Transcription Factor ETV1 Regulates Stromal Expansion and Metastasis in Pancreatic Cancer

Heeg, S., Das, K. K., Reichert, M., Bakir, B. S., Takano, S., Caspers, J., Aiello, N. M., Wu, K., Neeße, A., Maitra, A., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.06.005 · Cited by 65

Neoplasms of the Exocrine Pancreas

Wolff, R. A., Crane, C. H., Li, D., Evans, D. B., Maitra, A., & Tsai, S. (2017) · Wiley eBooks · doi:10.1002/9781119000822.hfcm094 · Cited by 64

Interplays of glucose metabolism and KRAS mutation in pancreatic ductal adenocarcinoma

Liu, Y.-H., Hu, C., Hsu, Y.-S., & Lee, W. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05259-w · Cited by 74

Progression to pancreatic ductal adenocarcinoma from pancreatic intraepithelial neoplasia: Results of a simulation model

Peters, M. L. B., Eckel, A. L., Mueller, P. P., Tramontano, A. C., Weaver, D. T., Lietz, A. P., Hur, C., Kong, C. Y., & Pandharipande, P. V. (2018) · Pancreatology · doi:10.1016/j.pan.2018.07.009 · Cited by 70

Refining Cancer Management Using Integrated Liquid Biopsy

Qiu, J., Xu, J., Zhang, K., Gu, W., Nie, L., Wang, G., & Luo, Y. (2020) · Theranostics · doi:10.7150/thno.40677 · Cited by 63

An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis

Carbone, C., Piro, G., Fassan, M., Tamburrino, A., Mina, M. M., Zanotto, M., Chiao, P. J., Bassi, C., Scarpa, A., Tortora, G., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2635 · Cited by 62

Noncoding RNAs and pancreatic cancer

Peng, J. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i2.801 · Cited by 65

Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells

Lee, J., Snyder, E. R., Liu, Y., Gu, X., Wang, J., Flowers, B. M., Kim, Y. J., Park, S., Szot, G. L., Hruban, R. H., et al. (2017) · Nature Communications · doi:10.1038/ncomms14686 · Cited by 64

A KRAS wild type mutational status confers a survival advantage in pancreatic ductal adenocarcinoma

Windon, A. L., Loaiza‐Bonilla, A., Jensen, C. E., Randall, M. P., Morrissette, J. J. D., & Shroff, S. G. (2018) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo.2017.10.14 · Cited by 61

Mechanistic regulation of epithelial-to-mesenchymal transition through RAS signaling pathway and therapeutic implications in human cancer

Tripathi, K., & Garg, M. (2018) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-017-0441-3 · Cited by 62

Single‐cell sequencing defines genetic heterogeneity in pancreatic cancer precursor lesions

Kuboki, Y., Fischer, C. G., Guthrie, V. B., Huang, W., Yu, J., Chianchiano, P. E., Hosoda, W., Zhang, H., Zheng, L., Shao, X. M., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5194 · Cited by 61

The tumor microenvironment in pancreatic ductal adenocarcinoma: current perspectives and future directions

Herting, C. J., Karpovsky, I., & Lesinski, G. B. (2021) · Cancer and Metastasis Reviews · doi:10.1007/s10555-021-09988-w · Cited by 60

Pancreatic Cancer and Cellular Senescence: Tumor Microenvironment under the Spotlight

Cortesi, M., Zanoni, M., Pirini, F., Tumedei, M. M., Ravaioli, S., Rapposelli, I. G., Frassineti, G. L., & Bravaccini, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010254 · Cited by 62

Liquid biopsy in pancreatic cancer: the beginning of a new era

Yadav, D. K., Bai, X., Yadav, R. K., Singh, A., Li, G., Ma, T., Chen, W., & Liang, T. (2018) · Oncotarget · doi:10.18632/oncotarget.24809 · Cited by 62

Clinical Significance of GNAS Mutation in Intraductal Papillary Mucinous Neoplasm of the Pancreas With Concomitant Pancreatic Ductal Adenocarcinoma

Ideno, N., Ohtsuka, T., Matsunaga, T., Kimura, H., Watanabe, Y., Tamura, K., Aso, T., Aishima, S., Miyasaka, Y., Ohuchida, K., et al. (2014) · Pancreas · doi:10.1097/mpa.0000000000000258 · Cited by 60

GNAS Sequencing Identifies IPMN-specific Mutations in a Subgroup of Diminutive Pancreatic Cysts Referred to as “Incipient IPMNs”

Matthaei, H., Wu, J., Molin, M. D., Shi, C., Perner, S., Kristiansen, G., Lingohr, P., Kalff, J. C., Wolfgang, C. L., Kinzler, K. W., et al. (2014) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000117 · Cited by 59

Phase I/II Study of Refametinib (BAY 86-9766) in Combination with Gemcitabine in Advanced Pancreatic cancer

Laethem, J. V., Riess, H. B., Jassem, J., Haas, M., Martens, U. M., Weekes, C. D., Peeters, M., Ross, P. J., Bridgewater, J. A., Melichar, B., et al. (2016) · Targeted Oncology · doi:10.1007/s11523-016-0469-y · Cited by 60

Genome-Wide Somatic Copy Number Alterations in Low-Grade PanINs and IPMNs from Individuals with a Family History of Pancreatic Cancer

Hong, S., Vincent, A., Kanda, M., Leclerc, J., Omura, N., Borges, M. W., Klein, A. P., Canto, M. I., Hruban, R. H., & Goggins, M. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1075 · Cited by 59

Activation of WNT/β-Catenin Signaling Enhances Pancreatic Cancer Development and the Malignant Potential Via Up-regulation of Cyr61

Sano, M., Driscoll, D. R., DeJesus-Monge, W. E., Quattrochi, B., Appleman, V. A., Ou, J., Zhu, L. J., Yoshida, N., Yamazaki, S., Takayama, T., et al. (2016) · Neoplasia · doi:10.1016/j.neo.2016.11.004 · Cited by 14

The roles of FOXM1 in pancreatic stem cells and carcinogenesis

Quan, M., Wang, P., Cui, J., Gao, Y., & Xie, K. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-159 · Cited by 58

Genome-scale analysis identifies GJB2 and ERO1LB as prognosis markers in patients with pancreatic cancer

Zhu, T., Gao, Y., Chen, Y., Wang, Z., Yin, J., Mao, X., Li, X., Zhang, W., Zhou, H., & Liu, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.15068 · Cited by 57

The BRG1/SOX9 axis is critical for acinar cell–derived pancreatic tumorigenesis

Tsuda, M., Fukuda, A., Roy, N., Hiramatsu, Y., Leonhardt, L., Kakiuchi, N., Hoyer, K., Ogawa, S., Goto, N., Ikuta, K., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci94287 · Cited by 62

Acinar cell clonal expansion in pancreas homeostasis and carcinogenesis

Neuhöfer, P., Roake, C. M., Kim, S. J., Lu, R. J., West, R. B., Charville, G. W., & Artandi, S. E. (2021) · Nature · doi:10.1038/s41586-021-03916-2 · Cited by 60

Selective impact of CDK4/6 suppression on patient-derived models of pancreatic cancer

Witkiewicz, A. K., Borja, N. A., Franco, J., Brody, J. R., Yeo, C. J., Mansour, J., Choti, M. A., McCue, P., & Knudsen, E. S. (2015) · Oncotarget · doi:10.18632/oncotarget.3819 · Cited by 56

KRAS: the Achilles’ heel of pancreas cancer biology

Drizyte‐Miller, K., Talabi, T., Somasundaram, A., Cox, A. D., & Der, C. J. (2025) · Journal of Clinical Investigation · doi:10.1172/jci191939 · Cited by 70

EVI1 oncogene promotes KRAS pathway through suppression of microRNA-96 in pancreatic carcinogenesis

Tanaka, M., Suzuki, H. I., Shibahara, J., Kunita, A., Isagawa, T., Yoshimi, A., Kurokawa, M., Miyazono, K., Aburatani, H., Ishikawa, S., et al. (2013) · Oncogene · doi:10.1038/onc.2013.204 · Cited by 56

NF-κB and Pancreatic Cancer; Chapter and Verse

Silke, J., & O’Reilly, L. A. (2021) · Cancers · doi:10.3390/cancers13184510 · Cited by 55

Transcriptome analysis of pancreatic cancer reveals a tumor suppressor function for HNF1A

Hoskins, J. W., Jia, J., Flández, M., Parikh, H. M., Xiao, W., Collins, I. J., Emmanuel, M. A., Ibrahim, A. M., Powell, J. I., Zhang, L., et al. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu193 · Cited by 54

Identification of KCa3.1 Channel as a Novel Regulator of Oxidative Phosphorylation in a Subset of Pancreatic Carcinoma Cell Lines

Kovalenko, I., Glasauer, A., Schöckel, L., Sauter, D. R. P., Ehrmann, A., Sohler, F., Hägebarth, A., Novak, I., & Christian, S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160658 · Cited by 56

Use of Biomarkers and Imaging for Early Detection of Pancreatic Cancer

Kato, S., & Honda, K. (2020) · Cancers · doi:10.3390/cancers12071965 · Cited by 56

Multifaceted role for p53 in pancreatic cancer suppression

Mello, S. S., Flowers, B. M., Mazur, P. K., Lee, J. J., Müller, F., Denny, S. K., Ferreira, S., Hanson, K., Kim, S. K., Greenleaf, W. J., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211937120 · Cited by 55

GRP78 haploinsufficiency suppresses acinar-to-ductal metaplasia, signaling, and mutant Kras -driven pancreatic tumorigenesis in mice

Shen, J., Ha, D. P., Zhu, G., Rangel, D. F., Kobielak, A., Gill, P. S., Groshen, S. G., Dubeau, L., & Lee, A. S. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1616060114 · Cited by 53

New Developments in the Molecular Mechanisms of Pancreatic Tumorigenesis

Felsenstein, M., Hruban, R. H., & Wood, L. D. (2017) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000172 · Cited by 59

A genetic roadmap of pancreatic cancer: still evolving

Notta, F., Hahn, S. A., & Real, F. X. (2017) · Gut · doi:10.1136/gutjnl-2016-313317 · Cited by 54

Impact of the Monocarboxylate Transporter-1 (MCT1)-Mediated Cellular Import of Lactate on Stemness Properties of Human Pancreatic Adenocarcinoma Cells

Sandforth, L., Ammar, N., Dinges, L. A., Röcken, C., Arlt, A., Sebens, S., & Schäfer, H. (2020) · Cancers · doi:10.3390/cancers12030581 · Cited by 53

Precursor Lesions of Pancreatic Cancer

Kim, J. Y., & Hong, S. (2018) · Oncology Research and Treatment · doi:10.1159/000493554 · Cited by 52

Current Status of the Diagnosis of Early-Stage Pancreatic Ductal Adenocarcinoma

Nakaoka, K., Ohno, E., Kawabe, N., Kuzuya, T., Funasaka, K., Nakagawa, Y., Nagasaka, M., Ishikawa, T., Watanabe, A., Tochio, T., et al. (2023) · Diagnostics · doi:10.3390/diagnostics13020215 · Cited by 53

Epithelial-Myeloid cell crosstalk regulates acinar cell plasticity and pancreatic remodeling in mice

Zhang, Y., Yan, W., Mathew, E., Kane, K. T., Brannon, A., Adoumie, M., Vinta, A., Crawford, H. C., & di Magliano, M. P. (2017) · eLife · doi:10.7554/elife.27388 · Cited by 55

Heterotopic Pancreas of the Gastrointestinal Tract and Associated Precursor and Cancerous Lesions

Jun, S., Son, D., Kim, M., Kim, S. J., An, S., Park, Y. S., Park, S. R., Choi, K. D., Jung, H., Kim, S. C., et al. (2017) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000850 · Cited by 51

Effective screening for early diagnosis of pancreatic cancer

Hanada, K., Okazaki, A., Hirano, N., Izumi, Y., Minami, T., Ikemoto, J., Kanemitsu, K., & Hino, F. (2015) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2015.09.017 · Cited by 51

IER3 supports KRASG12D-dependent pancreatic cancer development by sustaining ERK1/2 phosphorylation

Garcia, M. N., Grasso, D., López‐Millán, B., Hamidi, T., Loncle, C., Tomasini, R., Lomberk, G. A., Porteu, F., Urrutia, R. A., & Iovanna, J. (2014) · Journal of Clinical Investigation · doi:10.1172/jci76037 · Cited by 51

G4 DNA in ras genes and its potential in cancer therapy

Cogoi, S., & Xodo, L. E. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.02.002 · Cited by 51

KRAS Mutation Status and Treatment Outcomes in Patients With Metastatic Pancreatic Adenocarcinoma

Norton, C., Shaw, M. S., Rubnitz, Z., Smith, J. L., Soares, H. P., Nevala-Plagemann, C., Garrido‐Laguna, I., & Florou, V. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.53588 · Cited by 50

Diversity of Clinical Implication of B-Cell Translocation Gene 1 Expression by Histopathologic and Anatomic Subtypes of Gastric Cancer

Kanda, M., Oya, H., Nomoto, S., Takami, H., Shimizu, D., Hashimoto, R., Sueoka, S., Kobayashi, D., Tanaka, C., Yamada, S., et al. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3477-8 · Cited by 51

The Transcription Factor GLI1 Modulates the Inflammatory Response during Pancreatic Tissue Remodeling

Mathew, E., Collins, M. A., Fernández‐Barrena, M. G., Holtz, A. M., Yan, W., Hogan, J. O., Tata, Z., Allen, B. L., Fernández-Zapico, M. E., & di Magliano, M. P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.556563 · Cited by 52

Management of Intraductal Papillary Mucinous Neoplasms: Controversies in Guidelines and Future Perspectives

Levink, I. J. M., Bruno, M. J., & Cahen, D. W. (2018) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-018-0190-2 · Cited by 53

Epithelial-Stromal Interactions in Pancreatic Cancer

Zhang, Y., Crawford, H. C., & di Magliano, M. P. (2018) · Annual Review of Physiology · doi:10.1146/annurev-physiol-020518-114515 · Cited by 52

Exome Capture Sequencing of Adenoma Reveals Genetic Alterations in Multiple Cellular Pathways at the Early Stage of Colorectal Tumorigenesis

Zhou, D., Yang, L., Zheng, L., Ge, W., Li, D., Zhang, Y., Hu, X., Gao, Z., Xu, J., Huang, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053310 · Cited by 49

Pancreatic Fibroblast Heterogeneity: From Development to Cancer

Garcia, P. E., Scales, M. K., Allen, B. L., & di Magliano, M. P. (2020) · Cells · doi:10.3390/cells9112464 · Cited by 48

Pancreatic Ductal Adenocarcinoma: Molecular Pathology and Predictive Biomarkers

Taherian, M., Wang, H., & Wang, H. (2022) · Cells · doi:10.3390/cells11193068 · Cited by 52

Utility of serum DNA as a marker for KRAS mutations in pancreatic cancer tissue

Ako, S., Nouso, K., Kinugasa, H., Dohi, C., Matushita, H., Mizukawa, S., Muro, S., Akimoto, Y., Uchida, D., Tomoda, T., et al. (2016) · Pancreatology · doi:10.1016/j.pan.2016.12.011 · Cited by 47

Classification, Morphology, Molecular Pathogenesis, and Outcome of Premalignant Lesions of the Pancreas

Pittman, M. E., Rao, R. A., & Hruban, R. H. (2017) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2016-0426-ra · Cited by 49

Genome-Wide Somatic Copy Number Alterations and Mutations in High-Grade Pancreatic Intraepithelial Neoplasia

Hata, T., Suenaga, M., Marchionni, L., Macgregor-Das, A. M., Yu, J., Shindo, K., Tamura, K., Hruban, R. H., & Goggins, M. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.03.012 · Cited by 49

Germline Variants and Risk for Pancreatic Cancer

Zhan, W., Shelton, C. A., Greer, P. J., Brand, R. E., & Whitcomb, D. C. (2018) · Pancreas · doi:10.1097/mpa.0000000000001136 · Cited by 50

MYC-mediated resistance to trametinib and HCQ in PDAC is overcome by CDK4/6 and lysosomal inhibition

Silvis, M. R., Silva, D., Rohweder, R., Schuman, S. S., Gudipaty, S. A., Truong, A., Yap, J. T., Affolter, K. E., McMahon, M., & Kinsey, C. G. (2022) · The Journal of Experimental Medicine · doi:10.1084/jem.20221524 · Cited by 46

Next-generation therapies for pancreatic cancer

Buckley, C. W., & O'Reilly, E. M. (2024) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2024.2322648 · Cited by 49

B-cell translocation gene 1 serves as a novel prognostic indicator of hepatocellular carcinoma

Kanda, M., Sugimoto, H., Nomoto, S., Oya, H., Hibino, S., Shimizu, D., Takami, H., Hashimoto, R., Okamura, Y., Yamada, S., et al. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2762 · Cited by 49

Current concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ system

Voltaggio, L., Cimino‐Mathews, A., Bishop, J. A., Argani, P., Cuda, J. D., Epstein, J. I., Hruban, R. H., Netto, G. J., Stoler, M. H., Taube, J. M., et al. (2016) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21350 · Cited by 46

Genetic Alterations Associated With Progression From Pancreatic Intraepithelial Neoplasia to Invasive Pancreatic Tumor

Murphy, S. J., Hart, S. N., Lima, J. F., Kipp, B. R., Klebig, M. L., Winters, J. L., Szabo, C., Zhang, L., Eckloff, B. W., Petersen, G. M., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.07.049 · Cited by 199

Molecular genetics of pancreatic intraepithelial neoplasia

Feldmann, G., Beaty, R., Hruban, R. H., & Maitra, A. (2007) · Journal of Hepato-Biliary-Pancreatic Surgery · doi:10.1007/s00534-006-1166-5 · Cited by 269

Precursor Lesions of Pancreatic Cancer

Yonezawa, S., Higashi, M., Yamada, N., & Goto, M. (2008) · Gut and Liver · doi:10.5009/gnl.2008.2.3.137 · Cited by 91

KRAS2 Mutations in Human Pancreatic Acinar-Ductal Metaplastic Lesions Are Limited to Those with PanIN: Implications for the Human Pancreatic Cancer Cell of Origin

Shi, C., Hong, S., Lim, P., Kamiyama, H., Khan, M. A., Anders, R. A., Goggins, M., Hruban, R. H., & Eshleman, J. R. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0206 · Cited by 109

Mutational spectrum of intraepithelial neoplasia in pancreatic heterotopia

Ma, C., Gocke, C. D., Hruban, R. H., & Belchis, D. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.09.023 · Cited by 19